Wearable cuffless blood pressure monitor to guide care in uncontrolled hypertension
Tests a wearable cuffless monitor to guide treatment in adults with uncontrolled hypertension.
Key facts
- Who runs it
- Korea University Anam Hospital
- Where
- Ansan and Seoul, South KoreaSee the 3 sites
- Trial code
- Registry title
- CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 22 Oct 2025
- Expected to end
- 31 Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- CART BP Pro
- Usual Care
- Record updated
- 12 November 2026
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age ≥ 19 years
- Uncontrolled hypertension defined as office systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg
- Ability and willingness to provide written informed consent and comply with study procedures
Who cannot take part
- History of intolerance or contraindication to olmesartan, amlodipine, or hydrochlorothiazide
- Suspected secondary hypertension
- Any serious medical condition that may interfere with study participation or interpretation of study results
- Atrial fibrillation
- Pregnancy or lactation
Where in South Korea
- Korea University Ansan HospitalAnsan, South KoreaContact: Seung Yong Shin, MD PhDTaking people
- Korea University Anam HospitalSeoul, South KoreaContact: Hyung Joon JooTaking people
- Korea University Guro HospitalSeoul, South KoreaContact: Soohyung Park, MD PhDTaking people
About the trial
What the trial wants to find out
This multicenter, prospective, open-label randomized trial compares CART BP Pro-guided blood pressure management with usual care based on office blood pressure in Korean adults with uncontrolled hypertension. The planned enrollment is 400 participants at three Korea University hospitals. Participants are assigned in a 1:1 ratio to the two groups. CART BP Pro is a ring-type device that estimates blood pressure from optical pulse signals. Both groups receive guideline-based antihypertensive care.
Read full original descriptionShow less
The main outcome is the difference between groups in CART-derived, time-weighted 24-hour mean systolic blood pressure at the 24-week assessment, with an allowable assessment window of 16-32 weeks. Both groups undergo outcome assessment. Recording-quality rules allow some incomplete recordings, including early device return, while requiring sufficient duration and time coverage. Standardized office blood pressure, office blood pressure below 130/80 mmHg, other CART blood pressure measures, and adverse events are also assessed.
The 2 groups in the trial
- CART BP Pro-guided blood pressure managementTreatment being tested
Participants will undergo ambulatory blood pressure monitoring using the CART BP Pro wearable device. Antihypertensive medication adjustments will be guided by ambulatory blood pressure data obtained from the device.
Treatment: CART BP Pro
- Usual careExisting treatment, for comparison
Participants will receive standard hypertension management based on office blood pressure measurements according to current clinical guidelines.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy and Safety of Cuffless Ambulatory Blood Pressure Monitoring Device-Guided Blood Pressure Management Compared With Usual Care in Korean Patients With Uncontrolled Hypertension: A Multicenter Prospective Randomized Controlled Trial
- Plain-language title
- Wearable cuffless blood pressure monitor to guide care in uncontrolled hypertensionGenerated from the registry record. The registry title is the official one.
- Record updated
- 12 November 2026